Skip to content

Study on application of furosemide pump in early stage of reabsorption of critical burn

Study on application of furosemide pump in early stage of reabsorption of critical burn

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048459
Enrollment
Unknown
Registered
2021-07-09
Start date
2021-07-02
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical burn

Interventions

Experimental group:furosemide treatment
Control group:null

Sponsors

Anshan Hospital of the First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 60 years (18 years old<=age<=60 years old); 2. Patients with thermal (flame, hydrothermal) burns; 3. The total burn area is greater than or equal to 50% or the third degree is greater than or equal to 20% and there is no delayed resuscitation (no effective resuscitation within 6 hours after injury); 4. Admission to hospital within 24 hours after injury; 5. From July 1, 2021 to June 30, 2023, critically burned patients admitted to Anshan Hospital of the First Affiliated Hospital of China Medical University.

Exclusion criteria

Exclusion criteria: 1. Those who have serious adverse events, complications and special physiological changes, should not continue to be tested; 2. Those who withdraw by themselves during the test; 3. Cases who withdrew from the trial or were lost to follow-up due to various other reasons. 4. The information is incomplete, which affects the judgment of effectiveness or safety.

Design outcomes

Primary

MeasureTime frame
Blood routine examination;Serum ion concentration;Serum ion concentration;Procalcitonin;Lung CT;Heart rate;Blood pressure;Urine volume;

Countries

China

Contacts

Public ContactZhai Hongjun

Anshan Hospital of the First Hospital of China Medical University

hongjunzhai@163.com+86 18041201012

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026